EUVIMEDEUVIMED entdecken
Crossref

Does Minocycline Improve Recovery After Acute Ischemic Stroke?

Rajinder Singh, Sherwin Joy Augustin, Marlie Jane, Jocelyn M. Y. Cheong, Lee Sze Haur, Tai Bee Choo

Journal of Stroke Medicine · 2019

DOI: 10.1177/2516608519856263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Stroke Medicine, 2019. Verfasst von Rajinder Singh und 5 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We assessed the efficacy of minocycline in improving outcomes in acute ischemic stroke patients.

Method

This was a multicenter, randomized, double-blind, placebo-controlled clinical trial, where acute ischemic stroke patients were randomized to either oral minocycline or placebo within 3 to 48 hours of symptom onset. The primary endpoint was the modified Rankin (mRS) score at day 90. Secondary outcomes included the National Institutes of Health Stroke Scale (NIHSS) scores, the Barthel index, and vascular outcomes at day 90.

Results

A total of 139 subjects (73.4% male; mean age 62 [range 19-88] years) were randomized to receive minocycline (n = 69) or placebo (n = 70). At day 90, no significant difference was noted in the proportion of subjects given minocycline with mRS score ≤1 compared to placebo (56% versus 51%). The odds ratio of favorable outcome in the minocycline group compared to placebo was 1.20 (95% CI [0.58, 2.47], P = 0.60). No difference was recorded between the 2 groups in secondary outcomes of the NIHSS score (OR 1.11: 95% CI [0.98, 2.54]), the Barthel index (OR 0.78: 95% CI [0.33, 1.86]), or vascular events (OR 2.09 95% CI [0.29, 23.77]). A planned interim analysis was performed after approximately half the subjects reached the primary endpoint. The data and safety monitoring board recommended ending the trial for futility after determining that it was highly unlikely for minocycline to show significant efficacy over placebo in improving functional outcomes at day 90 if all subjects were randomized. No safety concerns were identified.

Interpretation

Oral minocycline administered for acute ischemic stroke was ineffective in improving functional outcomes.

Zitieren

APA

Singh, R., Augustin, S. J., Jane, M., Cheong, J. M. Y., Haur, L. S., & Choo, T. B. (2019). Does Minocycline Improve Recovery After Acute Ischemic Stroke?. Journal of Stroke Medicine. https://doi.org/10.1177/2516608519856263

Vancouver

Singh R, Augustin SJ, Jane M, Cheong JMY, Haur LS, Choo TB. Does Minocycline Improve Recovery After Acute Ischemic Stroke?. Journal of Stroke Medicine. 2019. doi:10.1177/2516608519856263

BibTeX
@article{Singh2019,
  author = {Singh, Rajinder and Augustin, Sherwin Joy and Jane, Marlie and Cheong, Jocelyn M. Y. and Haur, Lee Sze and Choo, Tai Bee},
  title = {Does Minocycline Improve Recovery After Acute Ischemic Stroke?},
  journal = {Journal of Stroke Medicine},
  year = {2019},
  doi = {10.1177/2516608519856263}
}
Kostenlos starten →